Home monitoring for heart failure management.
With a prevalence of 5.8 million in the United States alone, heart failure (HF) is a common syndrome associated with substantial morbidity, mortality, and healthcare expenditures. Close to 1 million HF hospitalizations occur annually in the United States, with the majority of these resulting from worsening congestion in patients previously diagnosed with HF. An estimated $37.2 billion is spent each year on HF in the United States. These statistics emphasize the need to develop and implement more effective strategies to assess, monitor, and treat HF. It has also become increasingly apparent that interventions geared toward identifying and monitoring subclinical congestion would be of value in the home management of chronic HF. Earlier identification and treatment of congestion together with improved care coordination, management of comorbid conditions, and enhanced patient self-management may help to prevent hospitalizations in patients with chronic HF. Such home monitoring extends from the promotion of self-care and home visitations to telemedicine and remote monitoring of external or implantable devices. This paper discusses the challenges in monitoring patients with HF, reviews clinical trials testing different monitoring strategies in HF, and highlights ongoing investigations into the optimal approaches to home monitoring for HF.
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, USA.
Anh L
AL
Bui
Gregg C
GC
Fonarow
D017147:Defibrillators, Implantable; D006333:Heart Failure; D006439:Hemodynamics; D006699:Home Care Services; D006801:Humans; D010138:Pacemaker, Artificial; D012648:Self Care; D017216:Telemedicine; D013686:Telemetry